Award of Options to Directors
19 Enero 2010 - 6:02AM
UK Regulatory
TIDMAGI
RNS Number : 7802F
AGI Therapeutics plc
19 January 2010
AGI Therapeutics plc ("AGI" or the "Company")
Award of Options to Directors
On 18th January, 2010, AGI awarded the following options over ordinary shares of
EUR0.01 each in the share capital of the Company ("Ordinary Shares") with an
exercise price of EUR0.08 in accordance with the Company's share option scheme.
Director Number of options Resulting number
over Ordinary Shares of options held
granted
John Devane1,260,000 3,290,160
Mary Martin1,260,0002,775,596
Patrick Ashe 840,0002,355,596
David Kelly840,0002,355,596
Ends
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAFFNFSNEEFF
AGI (LSE:AGI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
AGI (LSE:AGI)
Gráfica de Acción Histórica
De May 2023 a May 2024
Real-Time news about AGI (London Stock Exchange): 0 recent articles
Más de AGI Therapeutics plc Artículos de Noticias